Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-21

FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for doxazosin from Apotex Corp., indicating updated labeling/manufacturing aspects for the generic product. No new c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN)